ZeZentalis Pharma
ZNTL4.5200.22% ( +0.010 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: ZeZentalis Pharma(ZNTL) predict that the EBIT is -37.86 M (+17.03%), Miss estimate;the EPS is -0.5 (+25.37%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.04B17.03%
-0.04B18.23%
-0.00B1.20%
EPSMiss expectations
-0.525.37%
-0.472529.48%
-0.02754.11%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf